VetMedGuide

Vet Med Guide

Companion animal beside veterinary diagnostic materials.
Diagnostics2026-06-17 · 13 min read

Congestive Heart Failure in Dogs: Left vs Right, ACVIM Staging, Workup, and Prognosis

Congestive heart failure in dogs — left-sided vs right-sided signs, ACVIM MMVD staging, thoracic radiographs, NT-proBNP and echocardiogram, treatment, and life expectancy.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Congestive heart failure (CHF) is not a single disease — it is the endpoint at which a dog's heart can no longer pump effectively enough to keep fluid from backing up. In dogs, that endpoint is reached most often through myxomatous mitral valve disease (MMVD), a slow degeneration of the mitral valve that dominates cardiology in small-breed older dogs, and somewhat less often through dilated cardiomyopathy (DCM), which affects certain large breeds. Whatever the cause, the practical questions for an owner are the same: what the signs mean, whether this is an emergency, how veterinarians confirm fluid is backing up, what the treatment plan and staging mean, and what to expect over time.

This article is the condition-level workup for CHF in dogs. It is deliberately distinct from our drug-focused page on Vetmedin (pimobendan) for dogs and from our guide to evaluating a heart murmur in dogs — those cover the medication and the staging exam in depth, while this page ties the whole CHF picture together: left- versus right-sided failure, the ACVIM staging system, the diagnostic workup, the four-drug treatment backbone, the emergencies, and prognosis.

Quick answer

Congestive heart failure in dogs is the stage of heart disease at which fluid accumulates because the heart cannot keep up — pulmonary edema (fluid in the lungs) in left-sided failure, the more common form, causing cough, exercise intolerance, and rapid or labored breathing; or ascites and limb swelling in right-sided failure. Veterinarians stage MMVD on the ACVIM system (A, B1, B2, C, D), and CHF begins at Stage C. Diagnosis is built from the physical exam (a murmur), thoracic radiographs (an enlarged heart with perihilar pulmonary edema), an echocardiogram (the gold standard for structure and function), and a blood NT-proBNP level that helps separate a cardiac cough from a respiratory one. Treatment of chronic CHF rests on four medications — furosemide, pimobendan, an ACE inhibitor, and spironolactone — and dogs are typically started earlier, at Stage B2, with pimobendan alone to delay failure. Median survival after CHF develops (Stage C) is roughly 9 to 15 months, though some dogs live well beyond that; respiratory distress from pulmonary edema is the emergency that brings most dogs in.

What heart failure actually is

Heart failure means the heart's forward pump function has fallen behind the body's needs. When the left side fails, blood backs up into the left atrium and the pulmonary veins, pressure rises in the lung circulation, and fluid is pushed out into the lung tissue — pulmonary edema. When the right side fails, blood backs up into the body's veins, producing a swollen liver, ascites (free fluid in the abdomen), and sometimes swelling in the limbs. Many dogs with advanced disease have elements of both.

The key clinical insight is that the visible symptoms of CHF — the cough, the breathing trouble, the swollen belly — are fluid problems caused by a pump problem. Much of acute treatment is therefore about removing fluid (diuretics) and unloading the pump (pimobendan, ACE inhibitors), while the underlying valve or muscle disease continues to progress slowly in the background.

Left-sided vs right-sided failure

The distinction matters because the signs, the urgency, and sometimes the treatment differ.

Left-sided CHF is the more common and the more immediately dangerous form in dogs. Backed-up pressure floods the lungs. Typical signs:

  • A soft or persistent cough, sometimes producing froth
  • Tachypnea — a faster breathing rate, even at rest
  • Dyspnea — labored or effortful breathing
  • Exercise intolerance and early fatigue
  • Restlessness at night (some dogs cannot settle to sleep because they cannot breathe comfortably lying down)
  • In severe cases, blue-tinged (cyanotic) gums and collapse

Right-sided CHF is less immediately breath-threatening but produces dramatic fluid accumulation:

  • A distended, swollen abdomen (ascites)
  • Swelling in the legs or under the skin (peripheral edema)
  • Distended jugular veins
  • Lethargy, reduced appetite, and exercise intolerance

Some dogs present with biventricular failure — both patterns at once.

The ACVIM staging system (and where CHF begins)

Cardiologists stage MMVD using the American College of Veterinary Internal Medicine (ACVIM) consensus system, which classifies dogs by how far the disease has progressed rather than by a single test result. The stages:

  • Stage A — At high risk (predisposed breed) but no disease yet
  • Stage B — Structural heart disease present (a murmur with valve changes) but no signs of heart failure
    • B1 — No heart enlargement yet
    • B2 — Heart enlargement present; these are the dogs who benefit from starting pimobendan
  • Stage C — Heart failure is present, or has been present, and the dog is being (or needs to be) treated
  • Stage D — End-stage; signs of heart failure that are refractory to standard therapy

CHF, strictly speaking, is Stage C and beyond. A dog can have a murmur and an enlarged heart (Stage B2) and feel completely fine — which is exactly why staging and echocardiography matter: the goal is to intervene at B2 to delay the slide into C. Our Vetmedin for dogs page covers the EPIC trial evidence that pimobendan at Stage B2 delays the onset of CHF by roughly 15 months.

How veterinarians confirm CHF

A dog suspected of being in CHF typically gets a layered workup. Not every test is needed in every patient, but the combination is what makes the diagnosis robust.

  • History and physical exam. The signalment (an older Cavalier King Charles Spaniel, Dachshund, or other small breed), the story (new cough, faster breathing, exercise decline), and a murmur on auscultation raise the pre-test probability strongly.
  • Thoracic radiographs (chest X-rays). The first-line confirmatory test. Radiographs show an enlarged cardiac silhouette (often quantified by the vertebral heart score, VHS) and — in left-sided CHF — a characteristic interstitial-to-alveolar pattern centered in the perihilar (near the heart base) lung fields, which is pulmonary edema. Radiographs are also how treatment response is tracked (the edema should clear as furosemide works). Critically, radiographs may be postponed if the dog is too unstable to lie still — you stabilize first.
  • Echocardiogram (cardiac ultrasound). The gold standard for structure and function: it confirms MMVD, grades the mitral regurgitation, measures chamber enlargement (left atrium-to-aorta ratio, LA:Ao), estimates filling pressures, and identifies complicating findings like pulmonary hypertension. A focused or "limited" echo may be done during an acute crisis.
  • NT-proBNP blood test. A cardiac biomarker released when the heart is stretched. It is most useful for the coughing or breathless dog where it is unclear whether the cause is the heart or the lungs — a normal or near-normal NT-proBNP strongly argues against heart failure as the cause, while a high value supports it. It is an adjunct, not a standalone test.
  • Bloodwork and urine. To screen kidneys, electrolytes (potassium matters when diuretics and ACE inhibitors are in play), and concurrent disease before starting long-term cardiac drugs.
  • ECG / blood pressure. To assess rhythm (atrial fibrillation is common in DCM) and systemic pressure.

A common diagnostic trap: the chronic cough in an older small-breed dog. Collapsing trachea, chronic bronchitis, mainstem bronchial compression from an enlarged heart, and pulmonary hypertension can all mimic or coexist with CHF. NT-proBNP and radiographs (and echo, when available) are how a veterinarian separates a cardiac cough from a respiratory one — because the treatment is completely different, and giving a diuretic to a dog whose cough is actually collapsing trachea does not help.

Treatment

Treatment is organized by stage and by whether the dog is in an acute crisis or chronic maintenance.

Acute CHF (respiratory distress from pulmonary edema) is an emergency. Immediate management is injectable furosemide, supplemental oxygen, and gentle sedation (often butorphanol) to reduce the work of breathing and stress. Once the dog is stable and breathing more comfortably, oral medications are started and the dog is transitioned to home care. These patients often benefit from 24-hour hospital care and, where available, cardiology referral.

Chronic CHF (Stage C) maintenance rests on a four-medication backbone, continued indefinitely:

  • Furosemide (a loop diuretic) — removes the fluid; the dose is the main lever for symptom control. Needing to escalate furosemide above roughly 4 mg/kg/day while the dog is already on the full regimen is a sign of progression.
  • Pimobendan (an inodilator) — improves pump strength and reduces cardiac workload, and is one of the few drugs shown to extend life in CHF. Dosed at about 0.25–0.3 mg/kg twice daily on an empty stomach. (Our Vetmedin for dogs page covers this in depth.)
  • An ACE inhibitor (benazepril or enalapril) — blocks harmful neurohormonal activation. Added to furosemide and pimobendan as "triple therapy."
  • Spironolactone — a diuretic that also blocks aldosterone; the fourth drug ("quadruple therapy").

Stage B2 (before CHF) is treated with pimobendan alone — this is the EPIC-trial-supported intervention that delays the onset of heart failure, which is why early staging by echocardiogram matters so much.

Stage D (refractory) is managed by escalating therapy — higher or more frequent furosemide, switching to or adding torsemide (a more potent loop diuretic), adding drugs like sildenafil when pulmonary hypertension is present, and individualized specialist input.

Diet plays a supporting role: mild sodium restriction and maintaining good protein and calorie intake (and a healthy body condition score) matter more than aggressive salt elimination in dogs. The single most useful at-home monitoring tool owners are taught is the sleeping respiratory rate — counting breaths per minute while the dog is asleep or deeply resting; a sustained rise is often the earliest sign that fluid is returning and the diuretic dose needs attention.

What to expect (prognosis)

Heart failure in dogs is progressive and not curable, but it is treatable for a meaningful period, and quality of life is the central goal. Rough benchmarks from the cardiology literature:

  • Stage B2 dogs develop CHF within roughly 1 to 4 years of diagnosis without intervention; pimobendan extends the preclinical period, with a median time to CHF of about 3.5 years on treatment in the key study.
  • Stage C dogs have a reported median survival of about 9 to 15 months after CHF develops — but with wide spread. Roughly a quarter or more live beyond 18 months, and survival beyond two years is not uncommon. Quality of life during this time is often good with well-managed medications.
  • Stage D dogs — refractory to standard therapy — typically have a median survival of about 3 to 6 months.

These are population medians, not predictions for an individual dog. The factors that move an individual's outlook include the underlying disease (MMVD vs DCM), how early treatment was started, the presence of complications like pulmonary hypertension or atrial fibrillation, kidney function, and how consistently the owner can medicate and monitor.

The cause matters for prognosis. The benchmarks above fit best for MMVD-driven CHF. Dilated cardiomyopathy (DCM) — the dominant cause of heart failure in Doberman Pinschers, Boxers, Great Danes, Irish Wolfhounds, and some other large breeds — behaves differently and often more aggressively: an asymptomatic ("occult") DCM dog may go 1 to 4 years before symptoms, but sudden death is possible at any stage (particularly in Dobermans), and once heart failure develops, survival is often only roughly 3 to 12 months, with Dobermans on the shorter end. DCM also carries a higher burden of dangerous arrhythmias (atrial fibrillation and ventricular tachycardia), which is why ECG monitoring is a bigger part of DCM care. A separate and important point: some DCM cases are diet-associated — linked to grain-free or legume-heavy (pea, lentil, chickpea) diets in a connection the FDA has been investigating — and for those dogs, changing the diet can sometimes partially reverse the heart changes, which is not true of genetic MMVD. If your large-breed dog is newly diagnosed with DCM, ask whether a diet change and taurine assessment are appropriate alongside medication.

A common and reasonable owner question is whether heart failure is painful. Dogs in CHF do not typically show the kind of obvious pain you see with an injury, and the disease itself is usually described in terms of breathing discomfort and fatigue rather than pain — but the sensation of not being able to breathe is distressing, which is exactly why acute-treatment protocols prioritize oxygen and gentle sedation. If your dog seems painful, restless, or unable to settle, treat that as a reason to call your veterinarian, not a normal feature of the disease.

When it is an emergency

Call a veterinarian or emergency hospital immediately if a dog with known heart disease shows:

  • Rapid or labored breathing that does not settle, especially at rest
  • Respiratory distress, gasping, or blue-tinged gums
  • Coughing up froth or pink-tinged fluid
  • Collapse or fainting (syncope)
  • A swollen abdomen developing quickly with labored breathing

These can signal acute pulmonary edema and warrant the same urgency as any breathing emergency — minutes matter.

What to ask your veterinarian

  • If your dog has a murmur but no symptoms: "Has my dog had an echocardiogram, and is he or she at Stage B1 or B2 — meaning, should pimobendan be started now to delay heart failure?"
  • If your dog has just been diagnosed with CHF: "Which of the four standard medications is my dog on, what is each one for, and which require blood-test monitoring of the kidneys and potassium?"
  • About monitoring at home: "How do I measure a sleeping respiratory rate, and what number means I should call you or go to the emergency hospital?"
  • About the future: "Given my dog's stage and echo findings, what is a realistic prognosis and what would make you recommend cardiology referral?"

For related VetMedGuide cardiology content, see our guides to heart murmurs in dogs (the upstream finding that often leads to staging) and Vetmedin (pimobendan) for dogs (the medication at the center of MMVD treatment).

Sources

Topics
Cardiology
Related Articles